Embed this press release by copying the code below:
NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc.
NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc.